Molbio Diagnostics Ltd

NSE: MOLBIO · BSE: 544866 · Healthcare · 8 announcements

Share price: ₹1,246.00
Market cap: ₹14,359 Cr
Revenue (annual): ₹1,446 Cr
Net profit (annual): ₹166.6 Cr
Promoter holding: 41.29%
FII holding: 1.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 1 Capital Structure Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

25 Sep 2026 13:21 IST BSE

Board Meeting Outcome

Molbio Diagnostics Board Meeting Outcome

Molbio Diagnostics Limited has re-appointed M/s K. S. Kamalakara & Co as its Cost Auditor for the financial year 2026-27. The Board approved the appointment today.

Execution: Financial Year 2026-27

Read the filing ↗